Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Apr 2601:30 AM EDT
-02:30 AM EDT
Learn how Keshav, a Chartered Accountant, scored an impressive 705 on GMAT in just 30 days with GMATWhiz's expert guidance. In this video, he shares preparation tips and strategies that worked for him, including the mock, time management, and more.
Apr 2610:00 AM EDT
-11:00 AM EDT
The Target Test Prep course represents a quantum leap forward in GMAT preparation, a radical reinterpretation of the way that students should study. Try before you buy with a 5-day, full-access trial of the course for FREE!
Apr 2711:00 AM EDT
-12:00 PM EDT
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors
Apr 2808:00 AM PDT
-11:00 AM PDT
Whether you are just beginning your MBA journey or fine-tuning your path to a 700+ score, GMAT Day is designed to give you a competitive edge.
May 0111:00 AM PDT
-12:00 PM PDT
Free- full-length test + 15 concept videos + 150+ short videos + study plan!
09 Mar 2020, 08:25
Kudos
Bookmarks
B
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
45%
(medium)
Question Stats:
67% (02:02) correct
33%
(02:11)
wrong
based on 411
sessions
History
Date
Time
Result
Not Attempted Yet
Currently, prescription drug prices are set by drug companies according to market demands. A new regulation under consider would allow the government to require the drug manufacturers to sell certain drugs at lower prices in exchange of faster regulatory approvals for the drug themselves. This new practice would result in drug companies receiving less revenue per year for each drug available on the market and would therefore impede the development of new medicines.
Which of the following, if true, most strongly suggests that the new regulation favors drug manufacturers long-term economic interest?
A. Prescription drugs are normally purchased on advertising and efficacy and not pricing
B. Regulatory approval takes longer than two years during which time the manufacturer can not recover the heavy cost spent to develop the drug.
C. Two of the most expensive parts of the process by which manufacturers bring drug to market are the testing and approval procedures.
D. Regulation like the one under consideration was first enacted in a country where there is no patent protection for drugs developed for human consumption.
E. The lower prices required by government would still be higher than the prices of generic alternatives.
Source: 800score
Which of the following, if true, most strongly suggests that the new regulation favors drug manufacturers long-term economic interest?
A. Prescription drugs are normally purchased on advertising and efficacy and not pricing
B. Regulatory approval takes longer than two years during which time the manufacturer can not recover the heavy cost spent to develop the drug.
C. Two of the most expensive parts of the process by which manufacturers bring drug to market are the testing and approval procedures.
D. Regulation like the one under consideration was first enacted in a country where there is no patent protection for drugs developed for human consumption.
E. The lower prices required by government would still be higher than the prices of generic alternatives.
Source: 800score
25 Mar 2020, 01:42
Kudos
Bookmarks
Premise: 1) Currently drug prices ~ market demands. A new regulation : drugs at lower prices in exchange of faster regulatory approvals for the drug themselves.
Conclusion: This new practice would result in drug companies receiving less revenue per year for each drug available on the market and would therefore impede the development of new medicines.
Which of the following, if true, most strongly suggests that the new regulation favors drug manufacturers long-term economic interest?
Prethink : To support this long-term economic interest- relate to Faster regulatory approvals
A. Prescription drugs are normally purchased on advertising and efficacy and not pricing : Out of scope
B. Regulatory approval takes longer than two years during which time the manufacturer can not recover the heavy cost spent to develop the drug. --> Correct in line with prethinking.
C. Two of the most expensive parts of the process by which manufacturers bring drug to market are the testing and approval procedures. : How Faster approval will help? cost cud be same after regulation.
D. Regulation like the one under consideration was first enacted in a country where there is no patent protection for drugs developed for human consumption.: Irrelevant
E. The lower prices required by government would still be higher than the prices of generic alternatives. : Irrelevant
Conclusion: This new practice would result in drug companies receiving less revenue per year for each drug available on the market and would therefore impede the development of new medicines.
Which of the following, if true, most strongly suggests that the new regulation favors drug manufacturers long-term economic interest?
Prethink : To support this long-term economic interest- relate to Faster regulatory approvals
A. Prescription drugs are normally purchased on advertising and efficacy and not pricing : Out of scope
B. Regulatory approval takes longer than two years during which time the manufacturer can not recover the heavy cost spent to develop the drug. --> Correct in line with prethinking.
C. Two of the most expensive parts of the process by which manufacturers bring drug to market are the testing and approval procedures. : How Faster approval will help? cost cud be same after regulation.
D. Regulation like the one under consideration was first enacted in a country where there is no patent protection for drugs developed for human consumption.: Irrelevant
E. The lower prices required by government would still be higher than the prices of generic alternatives. : Irrelevant
22 Sep 2020, 00:25
Kudos
Bookmarks
Hi,
Can anyone please elobarate on why B is the correct answer?
Isn't B supporting the idea that drug manufacturer income will be less? We have to show that new regulation favors drug manufacturers long-term economic interest ryt? Then how is B the correct answer?
Can anyone please elobarate on why B is the correct answer?
Isn't B supporting the idea that drug manufacturer income will be less? We have to show that new regulation favors drug manufacturers long-term economic interest ryt? Then how is B the correct answer?
